The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,339K data for 617K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

13 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Kinetic and Structural Insights into the Mechanism of Binding of Sulfonamides to Human Carbonic Anhydrase by Computational and Experimental Studies.EBI
Istituto Italiano Di Tecnologia
1,3,4-Thiadiazoles: a potent multi targeted pharmacological scaffold.EBI
University Of Mississippi
Diarylsulfonamides and their bioisosteres as dual inhibitors of alkaline phosphatase and carbonic anhydrase: Structure activity relationship and molecular modelling studies.EBI
Forman Christian College (A Chartered University)
Sulfamates of methyl triterpenoates are effective and competitive inhibitors of carbonic anhydrase II.EBI
Martin-Luther-Universit£T Halle-Wittenberg
New aminobenzenesulfonamide-thiourea conjugates: synthesis and carbonic anhydrase inhibition and docking studies.EBI
Comsats Institute Of Information Technology
Correlation analyses on binding affinity of substituted benzenesulfonamides with carbonic anhydrase using ab initio MO calculations on their complex structures (II).EBI
The University Of Tokushima Graduate School
Recent developments in fragment-based drug discovery.EBI
Astex Therapeutics
Benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulfonamides as inhibitors of carbonic anhydrase.EBI
Institute Of Biotechnology
Synthesis and structure-activity relationships of novel benzene sulfonamides with potent binding affinity for bovine carbonic anhydrase II.EBI
Griffith University
Etoricoxib.BDB
Adis International